Skip to content
2000
  1. Home
  2. A-Z Publications
  3. New Emirates Medical Journal
  4. Volume 5, Issue 1
  5. Article
Volume 5, Issue 1
  • ISSN: 0250-6882
  • E-ISSN: 0250-6882
file format pdf download PDF
side by side viewer icon HTML

Abstract

Background

The incidence of renal neoplasms has been increasing globally. Immunohistochemistry aids in differentiating the subtypes of Renal Cell Carcinoma (RCC).

Objective

This study aimed to describe the demography of renal cancer in the Kingdom of Bahrain, comparing it to other regions worldwide, emphasizing the most common type of renal cancer, clinical presentation, and immunohistochemistry.

Methodology

This retrospective chart review comprises 74 Bahraini patients diagnosed with Renal neoplasms (from 2009-2019) at the Bahrain Defense Force (BDF) Hospital in the Kingdom of Bahrain. Variables collected include demographics, clinical presentation from patients’ electronic records and pathology registry, surgical management, immunohistochemistry, pathological staging, grading, and prognosis. IBM SPSS Statistics, version 28.0.0.0, was used.

Results

About 71 patients’ characteristics were analyzed; 63 had malignant neoplasms, and 8 had benign neoplasms. The mean age of patients with a malignant renal neoplasm was 56.38 (± 12.643). The most common presentation was an incidental finding (60.6% of lesions being right-sided). Clear Cell RCC was the most common malignant lesion (77.1%), and the most common stage was stage 1 (69.8%). CD10 and vimentin were 100% sensitive for Clear Cell RCC. No significant association was found between diabetes and a higher Fuhrman grade (3 or 4) ( 0.066).

Conclusion

From 2009 to 2019, renal neoplasms incidence increased. The most common malignant neoplasm was clear cell RCC and among benign tumours was oncocytoma. Immunohistochemistry plays an important role in subtype determination. One recommendation would be to assess the incidence of renal neoplasms in other hospitals in Bahrain to establish more epidemiological data and compare our results with other Gulf hospitals.

© 2024 The Author(s). Published by Bentham Science Publisher.
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/nemj/10.2174/0102506882270597231124104130
2024-01-01
2025-07-12

  • From This Site

    /content/journals/nemj/10.2174/0102506882270597231124104130
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
The full text of this item is not currently available.

References

  1. GuptaK. MillerJ.D. LiJ.Z. RussellM.W. CharbonneauC. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review.Cancer Treat. Rev.200834319320510.1016/j.ctrv.2007.12.00118313224
     [Google Scholar]
  2. SiegelR.L. MillerK.D. JemalA. Cancer statistics, 2015.CA Cancer J. Clin.201565152910.3322/caac.2125425559415
     [Google Scholar]
  3. BrayF. FerlayJ. SoerjomataramI. SiegelR.L. TorreL.A. JemalA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J. Clin.201868639442410.3322/caac.2149230207593
     [Google Scholar]
  4. SiegelR.L. MillerK.D. JemalA. Cancer statistics, 2020.CA Cancer J. Clin.202070173010.3322/caac.2159031912902
     [Google Scholar]
  5. ChevilleJ.C. LohseC.M. ZinckeH. WeaverA.L. BluteM.L. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma.Am. J. Surg. Pathol.200327561262410.1097/00000478‑200305000‑0000512717246
     [Google Scholar]
  6. GrignonD.J. CheM. Clear cell renal cell carcinoma.Clin. Lab. Med.200525230531610.1016/j.cll.2005.01.01215848738
     [Google Scholar]
  7. JonaschE GaoJ RathmellWK Renal cell carcinoma.BMJ2014349g479710.1136/bmj.g4797
     [Google Scholar]
  8. PadalaS.A. BarsoukA. ThandraK.C. SaginalaK. MohammedA. VakitiA. RawlaP. BarsoukA. Epidemiology of renal cell carcinoma.World J. Oncol.2020113798710.14740/wjon127932494314
     [Google Scholar]
  9. AlawadS. AlghamdiM. AlharbiM. AddarA. Al KhayalA. AlaskerA. Characteristics of renal cell carcinoma in Saudi patients below the age of 50 years.Urol. Ann2022141152010.4103/ua.ua_14_2135197697
     [Google Scholar]
  10. ThotathilZ.S. VargheseA. RaghebA. Renal cell carcinoma: The experience of Kuwait Cancer Control Center, Kuwait.Med. Princ. Pract.20051411510.1159/00008191415608473
     [Google Scholar]
  11. VenniyoorA. EssamA.M. RamadhanF. KeswaniH. MehdiI. BahraniB.A. High occurrence of non-clear cell renal cell carcinoma in Oman.Asian Pac. J. Cancer Prev.20161762801280427356693
     [Google Scholar]
  12. KhauliR. KhauliM. HeidarN.A. DegheiliJ.A. HakamN. Al-MoussawyM. ShahaitM. El-AsmarJ. BustrosG. MerheA. NasrR. BulbulM. WazzanW. El-HajjA. ShamseddineA. KfouryH. MukherjiD. Comparative analysis of histopathological subtypes of renal cell carcinoma in the Middle East compared to other world regions.Urol. Ann202113213013310.4103/UA.UA_172_2034194138
     [Google Scholar]
  13. ShenS.S. TruongL.D. ScarpelliM. Lopez-BeltranA. Role of immunohistochemistry in diagnosing renal neoplasms: When is it really useful?Arch. Pathol. Lab. Med.2012136441041710.5858/arpa.2011‑0472‑RA22458903
     [Google Scholar]
  14. LeibovichB.C. BluteM.L. ChevilleJ.C. LohseC.M. WeaverA.L. ZinckeH. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.J. Urol.200417131066107010.1097/01.ju.0000113274.40885.db14767272
     [Google Scholar]
  15. BamiasA. EscudierB. SternbergC.N. ZagouriF. DellisA. DjavanB. TzannisK. KontovinisL. StravodimosK. PapatsorisA. MitropoulosD. DeliveliotisC. DimopoulosM.A. ConstantinidesC.A. Current clinical practice guidelines for the treatment of renal cell carcinoma: A systematic review and critical evaluation.Oncologist201722666767910.1634/theoncologist.2016‑043528592625
     [Google Scholar]
  16. TruongL.D. ShenS.S. Immunohistochemical diagnosis of renal neoplasms.Arch. Pathol. Lab. Med.201113519210910.5858/2010‑0478‑RAR.121204715
     [Google Scholar]
  17. KimM. JooJ.W. LeeS.J. ChoY.A. ParkC.K. ChoN.H. Comprehensive immunoprofiles of renal cell carcinoma subtypes.Cancers202012360210.3390/cancers1203060232150988
     [Google Scholar]
  18. JanahiE MohammedM. Cancer incidence and mortality in the kingdom of bahrain statistics and trends.Bahrain Medical Bulletin20223813034
     [Google Scholar]
  19. Al-KawariM. AlsayyadJ. BazarbashiS. Al-EidH. Al-LawatiJ. Al-LawatiN. Al-KhaterA-H. Al-MohannadiS. ElbashmiA. Ten-Year Cancer Incidence Among Nationals of the GCC States 1998-2007.Riyadh, Saudi ArabiaGulf Center for Cancer Control and Prevention
     [Google Scholar]
  20. MahasinS. AloudahN. Al-SurimiK. AlkhateebS. Epidemiology profile of renal cell carcinoma: A 10-year patients’ experience at King Abdulaziz Medical City, National Guard Health Affairs, Saudi Arabia.Urol. Ann2018101596410.4103/UA.UA_102_1729416277
     [Google Scholar]
  21. HäggströmC. RappK. StocksT. ManjerJ. BjørgeT. UlmerH. EngelandA. AlmqvistM. ConcinH. SelmerR. LjungbergB. TretliS. NagelG. HallmansG. JonssonH. StattinP. Metabolic factors associated with risk of renal cell carcinoma.PLoS One201382e5747510.1371/journal.pone.005747523468995
     [Google Scholar]
  22. AlzubaidiAN SekoulopoulosS PhamJ WalterV FuletraJG RamanJD Incidence and distribution of new renal cell carcinoma cases: 27-year trends from a statewide cancer registry.J Kidney Cancer VHL.202292712
     [Google Scholar]
  23. MaeharaC.K. SilvermanS.G. LacsonR. KhorasaniR. Journal club: Renal masses detected at abdominal CT: radiologists’ adherence to guidelines regarding management recommendations and communication of critical results.AJR Am. J. Roentgenol.2014203482883410.2214/AJR.13.1149725247948
     [Google Scholar]
  24. KaneC.J. MallinK. RitcheyJ. CooperbergM.R. CarrollP.R. Renal cell cancer stage migration.Cancer20081131788310.1002/cncr.2351818491376
     [Google Scholar]
  25. Khalil IbrahimA. Trends of adult primary malignant renal tumors over 6 years.Pak. J. Med. Sci.20132961385138824550959
     [Google Scholar]
  26. OnoY. KinukawaT. HattoriR. YamadaS. NishiyamaN. MizutaniK. OhshimaS. Laparoscopic radical nephrectomy for renal cell carcinoma: A five-year experience.Urology199953228028610.1016/S0090‑4295(98)00505‑69933040
     [Google Scholar]
  27. DunnM.D. PortisA.J. ShalhavA.L. ElbahnasyA.M. HeidornC. McDougallE.M. ClaymanR.V. Laparoscopic versus open radical nephrectomy: A 9-year experience.J. Urol.200016441153115910.1016/S0022‑5347(05)67131‑510992356
     [Google Scholar]
  28. RabahD. AbumostafaN. SulaihimA. ArafaM. Survey of urologic laparoscopic practice patterns in Saudi Arabia.J. Endourol.20102481293129510.1089/end.2010.000720629567
     [Google Scholar]
  29. RassweilerJ. FredeT. HenkelT.O. StockC. AlkenP. Nephrectomy: A comparative study between the transperitoneal and retroperitoneal laparoscopic versus the open approach.Eur. Urol.199833548949610.1159/0000196409643669
     [Google Scholar]
  30. BreishM.O. WhitingD. SriprasadS. Laparoscopic nephrectomy in patients with previous abdominal surgery.Cureus2020122e699110.7759/cureus.699132190519
     [Google Scholar]
  31. FanX. XuK. LinT. LiuH. YinZ. DongW. HuangH. HuangJ. Comparison of transperitoneal and retroperitoneal laparoscopic nephrectomy for renal cell carcinoma: A systematic review and meta‐analysis.BJU Int.2013111461162110.1111/j.1464‑410X.2012.11598.x23106964
     [Google Scholar]
  32. CarvalhoJ.C. WascoM.J. KunjuL.P. ThomasD.G. ShahR.B. Cluster analysis of immunohistochemical profiles delineates CK7, vimentin, S100A1 and C‐kit (CD117) as an optimal panel in the differential diagnosis of renal oncocytoma from its mimics.Histopathology201158216917910.1111/j.1365‑2559.2011.03753.x21323945
     [Google Scholar]
  33. ShaM. MumtazF. Renal tumor biopsies: A shift towards improving outcomes in the management of small renal masses.STEM Education - Recent Trends and New Advancesintechopen202010.5772/intechopen.85781
     [Google Scholar]
  34. BarwariK. de la RosetteJ.J. LagunaM.P. The penetration of renal mass biopsy in daily practice: A survey among urologists.J. Endourol.201226673774710.1089/end.2011.040722201614
     [Google Scholar]
  35. MarconiL. DabestaniS. LamT.B. HofmannF. StewartF. NorrieJ. BexA. BensalahK. CanfieldS.E. HoraM. KuczykM.A. MerseburgerA.S. MuldersP.F.A. PowlesT. StaehlerM. LjungbergB. VolpeA. Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal tumour biopsy.Eur. Urol.201669466067310.1016/j.eururo.2015.07.07226323946
     [Google Scholar]
  36. PatelH.D. JohnsonM.H. PierorazioP.M. SozioS.M. SharmaR. IyohaE. BassE.B. AllafM.E. Diagnostic accuracy and risks of biopsy in the diagnosis of a renal mass suspicious for localized renal cell carcinoma: Systematic review of the literature.J. Urol.201619551340134710.1016/j.juro.2015.11.02926901507
     [Google Scholar]
  37. FinelliA. IsmailaN. BroB. DurackJ. EggenerS. EvansA. GillI. GrahamD. HuangW. JewettM.A.S. LatchaS. LowranceW. RosnerM. ShayeganB. ThompsonR.H. UzzoR. RussoP. Management of small renal masses: American society of clinical oncology clinical practice guideline.J. Clin. Oncol.201735666868010.1200/JCO.2016.69.964528095147
     [Google Scholar]
  38. LiawC.W. WinokerJ.S. MehrazinR. Imaging protocols for active surveillance in renal cell carcinoma.Curr. Urol. Rep.201819108110.1007/s11934‑018‑0830‑z30105557
     [Google Scholar]
  39. PandharipandeP.V. GervaisD.A. HartmanR.I. HarisinghaniM.G. FeldmanA.S. MuellerP.R. GazelleG.S. Renal mass biopsy to guide treatment decisions for small incidental renal tumors: A cost-effectiveness analysis.Radiology2010256383684610.1148/radiol.1009201320720070
     [Google Scholar]
/content/journals/nemj/10.2174/0102506882270597231124104130
Loading
A Comparative Analysis of Renal Neoplasms with Immunohistochemistry Study: Bahrain Experience
NEW Emirates Medical J 5, e02506882270597 (2024); https://doi.org/10.2174/0102506882270597231124104130
/content/journals/nemj/10.2174/0102506882270597231124104130
/content/journals/nemj/10.2174/0102506882270597231124104130
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): Chromophobe carcinoma; Clear cell carcinoma; Oncocytoma; Papillary carcinoma; Renal biopsy; Renal neoplasms; Tumour markers

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test